Acadia Healthcare Company, Inc.
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $2.84B | $2.81B |
| Acute Inpatient Psychiatric Facilities | — | — |
| Specialty Treatment Facilities | — | — |
| Comprehensive Treatment Centers | — | — |
| Residential Treatment Centers | — | — |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | $76.4M | $86.8M |
| Operating Income | $604.4M | $608.6M |
| Operating Margin | 21.3% | 21.7% |
| Interest Expense | — | — |
| Pretax Income | $236.8M | $33.0M |
| Income Tax Expense | $37.2M | $28.8M |
| Net Income | $199.8M | $6.1M |
| Net Margin | 7.0% | 0.2% |
| EPS (Basic) | $2.30 | $0.07 |
| EPS (Diluted) | $2.30 | $0.07 |
| Shares Outstanding (Basic) | 86.9M | 85.7M |
| Shares Outstanding (Diluted) | 87.1M | 86.0M |
| Dividends Per Share | — | — |